Magdalena Kokoszka

Magdalena Kokoszka

Auto-generated profile, based on publicly available information

Magdalena Kokoszka

Department of Pediatric Otolaryngology, Department of Pediatric Surgery, Head and Neck Surgery Faculty of Medical Sciences, Medical University of Silesia Katowice Poland

Research Focus & Metrics

Academic Career Length

5Years (2022-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
3 August 2023 in International Archives of Allergy and Immunology
Verified
Journal Article
Open access
PDF file
MKMagdalena Kokoszka
Magdalena Kokoszka
GSGrażyna Stryjewska-Makuch
Grażyna Stryjewska-Makuch
AKAda Kantczak
Ada Kantczak
DGDorota Górny
Dorota Górny
JGJoanna Gluck
Joanna Gluck
Allergic fungal rhinosinusitis (AFRS) is primary, Th2-mediated, chronic rhinosinusitis, which is diagnosed when the criteria defined by Bent and Khun are met. The disease is most common in countries located in the subtropical and tropical regions characterized by high temperatures and high levels of humidity, which favour the wider occurrence of fungi in the environment. The presence of specific IgE antibodies directed against fungal allergens, which is one of the diagnostic criteria, proves the systemic nature of the disease and allows one to distinguish AFRS from eosinophilic fungal rhinosinusitis. There is no unified treatment method for AFRS described in the literature, and relapses are common. Sinus surgery remains the treatment of choice. Oral and topical steroid therapy plays an important role in the treatment process. The effectiveness of antifungal treatment and immunotherapy is unclear. Biological treatment, the results of which are promising, has raised great hopes. The aim of this study was to reveal how often AFRS occurs in European countries, what environmental factors influence its development, and how important it is to specify its diagnostic criteria and treatment methods. We present an overview of the available literature. In addition, we share our own experience and describe two cases of AFRS diagnosed and treated at our centre.

18 October 2022 in European Archives of Oto-Rhino-Laryngology
Verified
Journal Article
Open access
PDF file
GSGrażyna Stryjewska-Makuch
Grażyna Stryjewska-Makuch
MKMagdalena Kokoszka
Magdalena Kokoszka
KGKarolina Goroszkiewicz
Karolina Goroszkiewicz
OKOlga Karłowska-Bijak
Olga Karłowska-Bijak
BKBogdan Kolebacz
Bogdan Kolebacz
MMMaciej Misiołek
Maciej Misiołek
Background: The aim of the study was to present rare sinus syndromes known as silent sinus syndrome (SSS) and frontal sinus syndrome with excessive pneumatization and bone defects in the wall (pneumocele). The available literature describing pneumocele cases was reviewed. Methodology: PubMed and Science Direct databases were searched by two independent reviewers. The primary outcome was finding descriptions of the sinus pneumocele. In the end, papers on frontal sinus pneumocele that was not the result of trauma, congenital defects or comorbidities were selected. Moreover, the authors presented their own cases of SSS and pneumocele. Results: Twelve case reports of frontal sinus pneumocele were found, one own case was presented. In addition, 8 subjects with SSS, diagnosed and treated in the period from September 2017 to May 2022, were described. Conclusions: With the increasing number of patients suffering from sinus diseases and the growing number of endoscopic surgeries, the knowledge of rare sinus syndromes will increase the safety of the procedures performed.

25 April 2024 in Polish Archives of Internal Medicine
Verified
Journal Article
Closed access
GSGrażyna Stryjewska-Makuch
Grażyna Stryjewska-Makuch
MHMaria Humeniuk-Arasiewicz
Maria Humeniuk-Arasiewicz
MKMagdalena Kokoszka
Magdalena Kokoszka
KGKarolina Goroszkiewicz
Karolina Goroszkiewicz
JGJoanna Gluck
Joanna Gluck
DOI: 10.20452/pamw.16740, Published online: April 25, 2024, Authors: Grażyna Stryjewska-Makuch, Maria Humeniuk-Arasiewicz, Magdalena Kokoszka, Karolina Goroszkiewicz, Joanna Gluck

10 July 2025 in Allergy
Verified
Journal Article
Open access
GSGrażyna Stryjewska‐Makuch
Grażyna Stryjewska‐Makuch
MHMaria Humeniuk‐Arasiewicz
Maria Humeniuk‐Arasiewicz
MOMagdalena Onyszczuk
Magdalena Onyszczuk
MKMagdalena Kokoszka
Magdalena Kokoszka
MNMarcelina Niemiec-Urbanczyk
Marcelina Niemiec-Urbanczyk
JGJoanna Gluck
Joanna Gluck

28 January 2025
Verified
Preprint
Open access
GMGrażyna Stryjewska- Makuch
Grażyna Stryjewska- Makuch
MHMaria Humeniuk-Arasiewicz
Maria Humeniuk-Arasiewicz
MOMagdalena Onyszczuk
Magdalena Onyszczuk
MKMagdalena Kokoszka
Magdalena Kokoszka
MNMarcelina Niemiec-Urbańczyk
Marcelina Niemiec-Urbańczyk
JGJoanna Gluck
Joanna Gluck
Chronic rhinosinusitis (CRS) is a complex, multifactorial inflammatory disease of the nasal mucosa and paranasal sinuses, in which disruption of the integrity of the mucosal barrier initiates an inflammatory cascade. It results, among other things, in the formation of polyps, increased secretion and impaired sense of smell. The aim of the study was to investigate the effect of biological treatment with mepolizumab or dupilumab on the cytological examination of the nasal mucosa in CRSwNP patients. The study included 23 patients who underwent cytological examinations at least 3 times during 6 months of treatment. 21 patients were treated for 9 months. Samples were evaluated at 400x magnification and expressed as the mean of 50 high-power microscopic fields (HPF) that had been assessed. Ciliated cells, goblet cells, plasma cells, neutrophils, eosinophils and mast cells were counted. All patients had their sense of smell tested every 3 months using a visual analogue scale (VAS). During biological treatment of CRSwNP patients with mepolizumab and dupilumab, cytological examinations revealed an increase in the number of ciliated cells, a decrease in the number of eosinophils correlated with an improvement in the sense of smell on the VAS scale.

30 September 2024 in OphthaTherapy. Therapies in Ophthalmology
Verified
Journal Article
Open access
PDF file
OKOlga Karłowska-Bijak
Olga Karłowska-Bijak
MKMagdalena Kokoszka
Magdalena Kokoszka
Maciej MisiolekMaciej Misiolek
Maciej Misiolek
GMGrażyna Makuch-Stryjewska
Grażyna Makuch-Stryjewska
DPDominik Pawlicki
Dominik Pawlicki
Hormonal factors, atopy, viral infections, gastroesophageal reflux, ischemic heart disease and swimming in a pool are believed to affect the development of primary acquired nasolacrimal duct obstruction (PANDO). It is suggested that patients with PANDO have more advanced inflammatory lesions revealed by the tomographic examination of the paranasal sinuses. The authors’ aim was to answer the question whether there is a connection between the chronic inflammation and disruption of the microbiome of the nasal cavity and sinuses and the development of inflammation in the lacrimal ducts. Pubmed.gov was the information source. Years reviewed included 2018 to 2023. Inclusion criteria included presence of an abstract, pathology of the nasolacrimal ducts, acute and chronic inflammation of the nasolacrimal ducts, papers written in English, studies on humans, publications regarding pathology of the lacrimal sac and paranasal sinuses, case report. The exclusion criteria included: lack of abstract, pathologies of other sections of the drainage system, pathology of the nasolacrimal ducts, other than chronic or acute inflammation, papers written in a language other than English, lack of case report. No gender criterion was used. Based on the data available in the literature, only 7 studies described the co-occurrence of pathologies of the lacrimal ducts and paranasal sinuses. Only 4 publications contained information on the microbiome and identified Streptococcus intermedius and Staphylococcus aureus, and in 2 cases no increase in pathological flora was revealed. The question about the relationship between the microbiome of the lacrimal sac and the paranasal sinuses and their mutual impact on the developing inflammation has not been answered, which, according to the authors, requires further research.